Valeant Pharmaceuticals International’s former subsidiary in Argentina continues to be subject to a proceeding filed by the Argentine Antitrust Agency.
The Company was formerly known as ICN Pharmaceuticals Inc.
In July 2004, the Company was advised that the Argentine Antitrust Agency…
Valeant Pharmaceuticals International is in the process of defending Barbara M. Shows’ product liability lawsuit on Permax pending in the Circuit Court of Jefferson Davis County, Miss.
On April 23, 2008, the Company was served a complaint in a case…
An agreement to settle two shareholder derivative lawsuits purportedly filed on Valeant Pharmaceuticals International’s behalf in state court in Orange County, Calif., remains subject to court approval.
These suits are styled:
(i) Michael Pronko v. Timothy C. Tyson et al.,…
Valeant Pharmaceuticals International (f/k/a ICN Pharmaceuticals Inc.) continues cooperating with the U.S. Securities and Exchange Commission’s Formal Order of Investigation on events and circumstances surrounding trading of the Company’s common stock.
The Company is also subject to the investigation on its…
The shareholder derivative action filed in Delaware court, in which Valeant Pharmaceuticals International (f/k/a ICN Pharmaceuticals Inc.) is a nominal defendant, remains stayed.
The case is pending in the Court of Chancery of the state of Delaware, styled Sherwood v. Tyson,…
Valeant Pharmaceuticals International’s case against Michael O.
Leavitt and Andrew C. Von Eschenbach, in their official capacities
at the Food and Drug Administration, remains pending before the
U.S. District Court for the District of Delaware.
On Dec. 17, 2007, Spear…
Valeant Pharmaceuticals International, in its Form 10-Q dated Aug. 11, 2008, disclosed that it expects to be dismissed with prejudice from Kathleen M. O’Connor’s product liability lawsuit on Permax soon.
On Feb. 8, 2007, the Company was served with the…